- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.
Postmenopausal women already have a broad menu of locally administered estrogen therapy products to treat vulvar and vaginal atrophy.
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.
Some recent high-flying biotechs may be preparing for their next surge.